According to The Insight Partners market research study titled ‘Whole Exome Sequencing Market to 2027 – Global Analysis and Forecasts by Product & Service, Technology, Application and Geography. The global whole exome sequencing market is expected to reach US$ 3,812.0 Mn in 2027 from US$ 755.68 Mn in 2018. The market is estimated to grow with a CAGR of 19.8% from 2019-2027. The report highlights the trends prevalent in the global whole exome sequencing market and the factors driving the market along with those that act as challenges to its growth.
Worldwide entire exome sequencing market was fragmented side-effect and administration, innovation, and application. Based on the item and administration, the market is sectioned as frameworks, units and administrations. Administrations section is further sub-divided into sequencing administrations and information investigation (bioinformatics) and different administrations. In view of the innovation, the entire exome sequencing market is sectioned into sequencing by combination, particle semiconductor sequencing and different advancements. Based on the application, the entire exome sequencing market is divided into diagnostics, drug revelation and advancement, customized medication and others. Diagnostics portion is further sub-fragmented into malignant growth diagnostics, monogenic (mendelian) messes diagnostics, monogenic sorts of diabetes diagnostics and HIV diagnostics and other diagnostics.
The market for entire exome sequencing is supposed to become altogether because of variables, for example, decrease in time and cost for sequencing, rising need of sub-atomic finding and expanding application in drug revelation are probably going to drive the development of the entire exome sequencing market.
Get PDF Sample at @ https://www.theinsightpartners.com/sample/TIPRE00005519/
The exon is part of a genome which is responsible for making 1 or 2 percent of the entire genome of a person. All of the exon in a genome are together known as the exome. And thus, sequencing is of these is known as whole-exome sequencing. The whole-exome sequencing allows identifying the variations in the protein-coding sites of any gene compared to sequencing a few genes together. The whole-exome sequencing is preferred widely due to its property to identify a mutation in a single exon. Identifying mutation in at the original site makes whole-exome sequencing an efficient method and enable to identify possible disease-causing mutation.
The advancement in the field of genomics has led to a significant reduction in the time and cost of genome sequencing. The related cost of sequencing with different sequencing techniques and strategies are of interest as they influence the scope and scale of the genomic research studies. Thus, it makes whole-exome sequencing much-preferred method than whole-genome sequencing.
The major players operating in the whole exome sequencing market include, Thermo Fisher Scientific Inc., Illumina, Inc., Centogene AG, F. Hoffmann-La Roche AG, Psomagen, Inc. (previuosly Macrogen Corp.), Pacific Biosciences of California, Inc., Brooks Automation, Inc. (GENEWIZ, Inc.), Bio-Rad Laboratories, Inc., Eurofins Scientific and Stratos Genomics. The market has carried out various organic and inorganic growth strategies in the market which has assisted in strengthening their product offering in the market.
Get Report Sample - https://www.theinsightpartners.com/reports/whole-exome-sequencing-market
About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.
Contact Us:
If you have any queries about this report or if you would like further information, please contact us:
Contact Person: Sameer Joshi
E-mail: sales@theinsightpartners.com
Phone: +1–646–491–9876